LARS1 and COVID-19: There is growing evidence that cell surface expressed CLRs function as myeloid cell‐interacting partners for SARS‐CoV‐2 promoting pro‐inflammatory responses in COVID‐19 (Lempp et al, 2021; Lu et al, 2021).